Viewing Study NCT03302767


Ignite Creation Date: 2025-12-25 @ 12:55 AM
Ignite Modification Date: 2026-01-04 @ 10:48 PM
Study NCT ID: NCT03302767
Status: COMPLETED
Last Update Posted: 2021-05-04
First Post: 2017-05-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology
Sponsor: Institut BergoniƩ
Organization:

Study Overview

Official Title: CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology
Status: COMPLETED
Status Verified Date: 2021-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CAP'ONCO
Brief Summary: This patient support system is designed to help patients regain their professional activity after their treatment. It's a 3-Axis neuropsycho-social synergy on 3 axes:

* A weekly pluridisciplinary consultation in tandem (Social worker + Psychologist / Neuropsychologist)
* Monthly information meetings and workshops (TIC'Onco reunions: collective information times and Cogit'Onco workshops: cognitive workshops
* An information booklet "Prepare the work return" The aim of this research is to evaluate efficiency in term of quality of life improvement linked to work status, utility, feasibility and patients' satisfaction.

The aim of this research is to evaluate efficiency in term of quality of life improvement linked to work status, utility, feasibility and patients' satisfaction.
Detailed Description: Unmet need characterize in 4 points:

* Cancer and survival: challenges for cancer patients who want to work while being treated
* Cancer and career: Job instability for cancer patients
* Difficulties and isolation of patients due to a lack of coordination between healthcare professionals and colleagues/management
* Post-treatment cognitive troubles stress and hindered patient return to employment: chemo brain This research-action will propose and evaluate a concrete device: To maintain a professional activity with the support of CAP'Onco during treatment, to balance between quality of life, managing the "cancer event" and the psychosocial consequences for professional experience, to provide an early, durable and multimodal support to improve work keeping and anticipate return to employment

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2017-A01251-52 OTHER ANSM View